Specialists for Retinal macular dystrophy type 2

8 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Kai Zhang, MD
Rare Disease / Clinical Research
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
PI×2
Laura Andres-Martin, PhD
Rare Disease / Clinical Research
New York Stem Cell Foundation Research Institute
PI×1
Francis WB Sanders, MB BChir PhD FRCOphth
Rare Disease / Clinical Research
Hywel Dda University Health Board
PI×1
Karim Hammamji, MD
Rare Disease / Clinical Research
Centre hospitalier de l'Université de Montréal (CHUM)
PI×1
Roberto dell'Omo, MD
Rare Disease / Clinical Research
University of Molise
PI×1
Ciro Costagliola, Professor
Rare Disease / Clinical Research
University of Molise
PI×1
Ronald Klein, MD, MPH
Rare Disease / Clinical Research
University of Wisconsin, Madison
PI×1
Alberto L Gil, MD
Rare Disease / Clinical Research
Federal University of Health Science of Porto Alegre
PI×1 1

More about Retinal macular dystrophy type 2